Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron E Foster

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Blood|April 21, 2009
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor modelAntonio Di Stasi, Biagio De Angelis, Cliona M Rooney, et al.
Leukemia & Lymphoma|April 7, 2010
Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphomaJessica A Shafer, Conrad R Cruz, Ann M Leen, et al.
Plos One|August 13, 2013
Elimination of metastatic melanoma using gold nanoshell-enabled photothermal therapy and adoptive T cell transferAdham S Bear, Laura C Kennedy, Joseph K Young, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 16, 2013
The miR-223/nuclear factor I-A axis regulates glial precursor proliferation and tumorigenesis in the CNSStacey M Glasgow, Dylan Laug, Vita S Brawley, et al.
Blood|July 20, 2007
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytesConcetta Quintarelli, Juan F Vera, Barbara Savoldo, et al.
Neuron|April 17, 2012
Sox9 and NFIA coordinate a transcriptional regulatory cascade during the initiation of gliogenesisPeng Kang, Hyun Kyoung Lee, Stacey M Glasgow, et al.
Molecular Cancer|November 20, 2009
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regressionAaron E Foster, Fatma V Okur, Ettore Biagi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 5, 2009
Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7Juan F Vera, Valentina Hoyos, Barbara Savoldo, et al.
Molecular Therapy Oncolytics|February 12, 2019
Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal SwitchesMyLinh T Duong, Matthew R Collinson-Pautz, Eva Morschl, et al.
Leukemia|March 1, 2019
Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignanciesMatthew R Collinson-Pautz, Wei-Chun Chang, An Lu, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Blood|April 21, 2009
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor modelAntonio Di Stasi, Biagio De Angelis, Cliona M Rooney, et al.
Leukemia & Lymphoma|April 7, 2010
Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphomaJessica A Shafer, Conrad R Cruz, Ann M Leen, et al.
Plos One|August 13, 2013
Elimination of metastatic melanoma using gold nanoshell-enabled photothermal therapy and adoptive T cell transferAdham S Bear, Laura C Kennedy, Joseph K Young, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 16, 2013
The miR-223/nuclear factor I-A axis regulates glial precursor proliferation and tumorigenesis in the CNSStacey M Glasgow, Dylan Laug, Vita S Brawley, et al.
Blood|July 20, 2007
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytesConcetta Quintarelli, Juan F Vera, Barbara Savoldo, et al.
Neuron|April 17, 2012
Sox9 and NFIA coordinate a transcriptional regulatory cascade during the initiation of gliogenesisPeng Kang, Hyun Kyoung Lee, Stacey M Glasgow, et al.
Molecular Cancer|November 20, 2009
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regressionAaron E Foster, Fatma V Okur, Ettore Biagi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 5, 2009
Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7Juan F Vera, Valentina Hoyos, Barbara Savoldo, et al.
Molecular Therapy Oncolytics|February 12, 2019
Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal SwitchesMyLinh T Duong, Matthew R Collinson-Pautz, Eva Morschl, et al.
Leukemia|March 1, 2019
Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignanciesMatthew R Collinson-Pautz, Wei-Chun Chang, An Lu, et al.
Pageof 5